Home | Welcome to Contract Pharma   
Last Updated Thursday, May 23 2013
Print

Collaborations & Alliances

Related Searches:

Filter by:

February 20, 2013
To develop and commercialize multiple biosimilar candidates   Read More »
February 20, 2013
Will evaluate the SURE CHO-M Cell Line for R&D   Read More »
February 19, 2013
Provides access to enzyme technologies and services for API manufacture   Read More »
February 19, 2013
Will combine capabilities to develop plant-based biopharmaceuticals   Read More »
February 15, 2013
IGI to manufacture finished dose forms of cosmetic and OTC products   Read More »
February 14, 2013
Aims to identify and commercialize new technologies   Read More »
February 13, 2013
Will combine immune therapy with Albufuse technology   Read More »
February 13, 2013
Aims to improve manufacturing routes for selected APIs   Read More »
February 12, 2013
Aims to discover, commercialize small-molecule therapies   Read More »
February 12, 2013
BMS to market several OTC medicines in Latin America   Read More »
February 11, 2013
Chai to take over tubulin compound   Read More »
February 8, 2013
Will share global rights to marketed products   Read More »
February 7, 2013
To identify and develop antibacterial agents   Read More »
February 4, 2013
Aims to identify commercialization opportunities   Read More »
January 31, 2013
Ends investment in cancer drug   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On